Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Xspray Pharma

25.00 SEK

-0.60 %

Less than 1K followers

XSPRAY

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xspray Pharma

2019202020212022202320242025
Revenue
growth-%
EBITDA-41.8-45.8-89.1-123.5-172.5-278.5-151.3
EBIT-49.7-53.5-98.0-133.1-181.7-287.0-156.9
Profit before taxes-48.9-52.4-96.7-131.7-179.7-285.7-171.6
Net income-48.9-52.4-96.7-131.7-179.7-285.5-171.4
EPS-3.01-2.93-4.83-6.01-6.56-8.47-4.46
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%
EBIT-%
ROE-13.1 %-9.0 %-16.3 %-23.7 %-25.9 %-45.8 %-28.4 %
ROI-12.2 %-8.7 %-15.5 %-22.5 %-23.5 %-35.9 %-22.3 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.